The prevalence of uveitis in juvenile rheumatoid arthritis
| Autor: | John W. Simon, Jitka Zobal-Ratner, Richard J. Blocker, Albert W. Biglan, Ashok Sehgal, Brad Oren, John Lee |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
Male
medicine.medical_specialty Pediatrics Visual acuity Adolescent New York Visual Acuity Asymptomatic Screening Examination Uveitis Blurred vision Prevalence Humans Medicine Child Retrospective Studies business.industry Anti-Inflammatory Agents Non-Steroidal Infant Retrospective cohort study medicine.disease Arthritis Juvenile Surgery Ophthalmology Child Preschool Pediatrics Perinatology and Child Health Female Pediatric ophthalmology medicine.symptom business Juvenile rheumatoid arthritis Follow-Up Studies |
| Zdroj: | Journal of American Association for Pediatric Ophthalmology and Strabismus. 5:2-4 |
| ISSN: | 1091-8531 |
| DOI: | 10.1067/mpa.2001.111017 |
| Popis: | Background: Because asymptomatic uveitis has been an important cause of visual loss in children with juvenile rheumatoid arthritis, periodic ophthalmologic screenings of such patients have been recommended. Recently, some authors have found a decreased prevalence of uveitis in children with juvenile rheumatoid arthritis. Methods: We studied a total of 76 patients (63 girls and 13 boys, aged 1 to 16 years), referred to 3 pediatric ophthalmology practices between March 1976 and October 1999. Follow-up examinations were performed at intervals of 3 to 6 months according to current guidelines, during the following 6 months to 23 years (mean, 55 months). Results: Uveitis developed in 10 children (13%). Of these 10 children, 2 were symptomatic (blurred vision, discomfort) and 7 were diagnosed with uveitis at the initial visit. Only 1 patient had asymptomatic uveitis after initial negative findings on screening examination. Final visual acuity for all the compliant children in the uveitis group was better than 20/30. Discussion: The prevalence of uveitis in our study is similar to rates found by other recent authors. This decrease may reflect a tendency for systemic medications to prevent the development of ocular inflammation. We believe that screening guidelines should be reevaluated, especially for asymptomatic children with negative findings on initial examinations. (J AAPOS 2001;5:2-4) |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect